Position in NVO
as of Jun 30, 2026
· filed Aug 13, 2026
Position Value
$5,623,649
+$3,664,801 QoQ
Shares Held
117,306
+120.1% QoQ
Ownership
0.003%
of shares outstanding
% of Portfolio
0.16%
of 13F equity value
Holder Rank
#203
of 1,348 holders
Holding Since
Dec 2020
21 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in NVO Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026HANTZ FINANCIAL SERVICES, INC. holds $94,295,990 across 14 Drug Manufacturers - General names. NVO ranks #7 (6.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | JNJ |
Johnson & Johnson
|
84,317 | $21,413,988 | |
| 2 | LLY |
ELI LILLY & Co
|
10,017 | $12,014,691 | |
| 3 | ABBV |
AbbVie Inc.
|
45,381 | $11,419,674 | |
| 4 | NVS |
Novartis AG
|
68,779 | $10,779,044 | |
| 5 | MRK |
Merck & Co., Inc.
|
66,636 | $8,562,726 | |
| 6 | GSK |
GSK plc
|
159,568 | $8,364,554 | |
| 7 | NVO |
Novo Nordisk A S
This page
|
117,306 | $5,623,649 | |
| 8 | AZN |
Astrazeneca PLC
|
23,610 | $4,476,928 |
All Filings in NVO
Export CSV
21 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $5,623,649 | 117,306 | Shares | Sole | 2026-08-13 | |
| 2026-03-31 | $1,958,848 | 53,302 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $3,381,739 | 66,465 | Shares | Sole | 2026-02-09 | |
| 2025-09-30 | $3,186,568 | 57,426 | Shares | Sole | 2025-11-05 | |
| 2025-06-30 | $5,489,988 | 79,542 | Shares | Sole | 2025-08-04 | |
| 2025-03-31 | $6,731,166 | 96,935 | Shares | Sole | 2025-05-12 | |
| 2024-12-31 | $15,903,291 | 184,879 | Shares | Sole | 2025-01-23 | |
| 2024-09-30 | $21,763,019 | 182,775 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $26,405,044 | 184,987 | Shares | Sole | 2024-07-30 | |
| 2024-03-31 | $21,491,335 | 167,378 | Shares | Sole | 2024-08-06 | |
| 2023-12-31 | $18,213,613 | 176,062 | Shares | Sole | 2024-08-06 | |
| 2023-09-30 | $9,621,724 | 105,803 | Shares | Sole | 2024-08-06 | |
| 2023-06-30 | $2,211,083 | 13,663 | Shares | Sole | 2024-08-06 | |
| 2023-03-31 | $2,138,205 | 13,436 | Shares | Sole | 2024-08-06 | |
| 2022-12-31 | $1,507,281 | 11,137 | Shares | Sole | 2024-08-06 | |
| 2022-09-30 | $958,241 | 9,618 | Shares | Sole | 2024-08-06 | |
| 2022-06-30 | $297,406 | 2,669 | Shares | Sole | 2024-08-06 | |
| 2021-09-30 | $249,433 | 2,598 | Shares | Sole | 2024-08-06 | |
| 2021-06-30 | $217,048 | 2,591 | Shares | Sole | 2024-08-06 | |
| 2021-03-31 | $173,336 | 2,571 | Shares | Sole | 2024-08-06 | |
| 2020-12-31 | $207,943 | 2,977 | Shares | Sole | 2024-08-06 | |
| No filing history on record for this holder in this stock. | ||||||